Fair Way Pharmaceuticals Private Limited

Composition	Rabeprazole 20mg and Domperidone 30mg
Packaging Type	Box
Brand Name	Fairway
Shelf Life	24 Months
Brand	Fairway
Strength	50mg
Item Name	Rebose D

Product Description

This dual-action capsule combines Rabeprazole, a potent proton pump inhibitor, with Domperidone, a prokinetic agent, to deliver effective relief from gastroesophageal reflux disease (GERD), dyspepsia, bloating, and nausea. Rabeprazole inhibits excess gastric acid secretion, while Domperidone enhances gut motility and alleviates symptoms like fullness and vomiting. Ideal for once-daily dosing, this formulation offers improved digestive comfort and patient adherence in both clinical and hospital settings.

Pack Size	10*10 Capsules
Packaging Type	Strips
Brand Name	Fairway
Shelf Life	24 Months
Strength	20mg
Item Name	Ribus D

Product Description

This dual-action capsule combines Rabeprazole, a potent proton pump inhibitor, with Domperidone, a gastrointestinal motility enhancer, to provide comprehensive relief from upper GI symptoms. Rabeprazole effectively suppresses excessive gastric acid secretion, while Domperidone promotes gastric emptying and helps alleviate bloating, nausea, and reflux. Ideal for use in GERD, functional dyspepsia, and postprandial discomfort, Ribus D offers once-daily convenience and improved patient compliance in clinical and hospital settings.

Strength	60000 I.U
Brand Name	Fairway
Packing Size	1*8 Tablets
Shelf life	24 Month
Packing Type	Blister Packs
Item Name	Waycal 60K

Product Description

These high-strength vitamin D3 capsules help in the prevention and treatment of vitamin D deficiency. Cholecalciferol supports calcium absorption, promotes healthy bones, and strengthens the immune system. Ideal for individuals with low vitamin D levels, osteoporosis, or increased dietary requirements. Typically administered once weekly under medical supervision.

Pack Size	10*10 Capsules
Pack Type	Strip
Brand Name	Fairway
Shelf Life	24 Months
Strength	20mg

Product Description

This sustained-release capsule combines Rabeprazole, a proton pump inhibitor, with Levosulpiride, a prokinetic agent, to effectively treat gastroesophageal reflux disease (GERD), dyspepsia, and related gastrointestinal disorders. Rabeprazole suppresses excess gastric acid, while Levosulpiride enhances gastric motility and improves digestion. Designed for once-daily dosing, it offers targeted dual-action relief with improved patient compliance in clinical and hospital settings.